Current population · 2,231
Cefazolin for Methicillin-Susceptible Staphylococcus aureus Bacteremia.
Staphylococcus aureus Network Adaptive Platform (SNAP) Trial Group; Lee TC, B...
← ExplorerSource ↗Publication identity
Publication IDCPD-2172
Year2026
PMID42308484
DOI10.1056/NEJMoa2506905
JournalNot recorded
AuthorsStaphylococcus aureus Network Adaptive Platform (SNAP) Trial Group; Lee TC, B...
First authorStaphylococcus aureus Network Adaptive Platform (SNAP) Trial Group; Lee TC
Senior authorGiulier…See abstract for full author list ➔N Engl J Med.
Scientific classification
Research themeClinical infectious diseases
Pathogen groupStaphylococcus aureus / MRSA
Technology / methodClinical trial / therapy
Object stateOBSERVED
Provenance & boundary
Generated Passport: this is a derived view of the canonical publication object. Missing or unsupported information remains unfilled; no scientific interpretation or current-staff status is manufactured.
PopulationCIDM Publications · 2,231
Source statussource-derived / affiliation verification required
Investigator sourceMatthew O'Sullivan
Canonical source URLhttps://pubmed.ncbi.nlm.nih.gov/42308484/
Author / Colleague Reality Return
Return corrections about identity, authorship, paper-specific CIDM/CIDM-PH affiliation, metadata, source/provenance, figure/table linkage, evidence boundary, or links.
Feedback → source check → evidence status → warranted correction → versioned update.
Open feedback route →